ER stress affects processing of MHC class I-associated peptides by Granados, Diana P et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Immunology
Open Access Research article
ER stress affects processing of MHC class I-associated peptides
Diana P Granados1, Pierre-Luc Tanguay2, Marie-Pierre Hardy1, 
Étienne Caron1, Danielle de Verteuil1, Sylvain Meloche2 and 
Claude Perreault*1
Address: 1Department of Medicine, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada and 2Department 
of Pharmacology, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada
Email: Diana P Granados - dp.granados@umontreal.ca; Pierre-Luc Tanguay - pierre-luc.tanguay@umontreal.ca; Marie-Pierre Hardy - marie-
pierre.hardy@umontreal.ca; Étienne Caron - etienne.caron@umontreal.ca; Danielle de Verteuil - danielle.de.verteuil@umontreal.ca; 
Sylvain Meloche - sylvain.meloche@umontreal.ca; Claude Perreault* - claude.perreault@umontreal.ca
* Corresponding author    
Abstract
Background: Viral infection and neoplastic transformation trigger endoplasmic reticulum (ER)
stress. Thus, a large proportion of the cells that must be recognized by the immune system are
stressed cells. Cells respond to ER stress by launching the unfolded protein response (UPR). The
UPR regulates the two key processes that control major histocompatibility complex class I (MHC
I)-peptide presentation: protein synthesis and degradation. We therefore asked whether and how
the UPR impinges on MHC I-peptide presentation.
Results: We evaluated the impact of the UPR on global MHC I expression and on presentation of
the H2Kb-associated SIINFEKL peptide. EL4 cells stably transfected with vectors coding hen egg
lysozyme (HEL)-SIINFEKL protein variants were stressed with palmitate or exposed to glucose
deprivation. UPR decreased surface expression of MHC I but did not affect MHC I mRNA level nor
the total amount of intracellular MHC I proteins. Impaired MHC I-peptide presentation was due
mainly to reduced supply of peptides owing to an inhibition of overall protein synthesis.
Consequently, generation of H2Kb-SIINFEKL complexes was curtailed during ER stress, illustrating
how generation of MHC I peptide ligands is tightly coupled to ongoing protein synthesis. Notably,
the UPR-induced decline of MHC I-peptide presentation was more severe when the protein source
of peptides was localized in the cytosol than in the ER. This difference was not due to changes in
the translation rates of the precursor proteins but to increased stability of the cytosolic protein
during ER stress.
Conclusion: Our results demonstrate that ER stress impairs MHC I-peptide presentation, and
that it differentially regulates expression of ER- vs. cytosol-derived peptides. Furthermore, this
work illustrates how ER stress, a typical feature of infected and malignant cells, can impinge on cues
for adaptive immune recognition.
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Background
The ultimate role of the immune system in host defense is
to eliminate infected and transformed cells [1,2]. A funda-
mental feature of infected and neoplastic cells is that they
are stressed cells [3-5]. In line with this, the innate
immune system uses receptors such as NKG2D to recog-
nize stressed cells [4,6,7]. One key question, however, is
whether cellular stress can influence recognition of trans-
formed or infected cells by the adaptive immune system
[4,8].
The single feature uniting different stress stimuli (heat
shock, hypoxia, viral replication, abnormal proteins, star-
vation or transformation) is that they all ultimately lead
to accumulation of unfolded or misfolded proteins in the
lumen of the ER [4,5]. Infection and neoplastic transfor-
mation increase protein translation and thereby the fold-
ing demand on the ER [9,10]. This is particularly true for
cells submitted to hypoxia, nutrient deprivation or low
pH in poorly vascularized bulky tumors, metastases and
sites of inflammation [11,12]. Moreover, acquisition of
numerous mutations during tumor progression leads to
accumulation of abnormal proteins with an increased
propensity to misfolding that further raises the ER folding
burden [3,13].
The ER responds to the accumulation of unfolded pro-
teins by activating intracellular signal transduction path-
ways, collectively called the unfolded protein response
(UPR) [14,15]. The UPR is a highly conserved adaptive
response that allows survival to limited stress but leads to
apoptosis in the presence of overwhelming stress [16,17].
Mammalian UPR acts through three main transducers
(PERK, ATF6 and IRE1) that are activated by dissociation
of the master chaperone BiP/GRP78 [5,15]. Activation of
PERK leads to phosphorylation of the translation initia-
tion factor eIF2α and attenuation of cap-dependent trans-
lation [18]. The endonuclease activity of IRE1 generates a
frameshift splice variant of XBP-1 encoding an active tran-
scription factor that activates genes involved in protein
degradation and controls the transcription of chaperones
[19-21]. Targets of the cleaved active form of ATF6 include
the chaperones BiP and GRP94, and the transcription fac-
tors XBP-1 and CHOP [17,19]. Activation of these UPR
transducers has pervasive effects on cellular protein econ-
omy: i) attenuation of protein translation, ii) increased
degradation of ER proteins by ER-associated degradation
(ERAD), iii) transcriptional activation of genes involved
in the folding machinery of the ER and iv) increased deg-
radation of ER-localized mRNAs [14,22].
Presentation of MHC I-associated peptides to CD8 T cells
is tightly linked to protein economy. MHC I peptides are
preferentially generated from newly synthesized but rap-
idly degraded polypeptides relative to slowly degraded
proteins [23,24]. Following proteasomal degradation,
peptides are translocated into the ER where they undergo
N-terminal trimming, loading onto MHC I/β2-microglob-
ulin (β2m) heterodimers and export at the cell surface
[25-29]. Since the UPR regulates the two key processes
that shape MHC I peptide processing (protein translation
and degradation) we reasoned that ER stress should
impinge on MHC I peptide presentation. We addressed
this question and found that MHC I presentation was
impaired during ER stress induced by palmitate or glucose
starvation. Moreover, ER stress differentially affected pres-
entation of peptides derived from a protein localized in
the ER vs. the cytosol.
Results
Engineering of Kb-SIINFEKL stable transfectant cell lines
Evidence suggests that subcellular localization of a protein
(e.g., in the cytosol vs. the secretory pathway) may influ-
ence MHC I presentation of peptides derived from that
specific protein [30-32]. Moreover, the UPR is primarily
orchestrated to decrease protein overload in the ER
[14,15]. We therefore wished to determine whether the
UPR would differentially affect MHC I presentation of
peptides derived from a precursor protein located in the
cytosol versus the ER. To this end, we created stable EL4
transfectant cell lines expressing a chimeric protein
located either in the ER or the cytoplasm (Figure 1A). We
selected the EL4 thymoma cell line as a model because it
expresses relatively high levels of MHC I [33] which
allows us to assess changes of MHC I abundance over a
wide dynamic range. To create the chimeric constructs, a
minigene coding for the SIINFEKL peptide was fused to
previously described plasmids encoding hen egg lys-
ozyme (HEL) targeted to the ER or the cytosol [34,35] (see
methods). The ovalbumin-derived SIINFEKL peptide is
presented by H2Kb and cell surface expression of Kb-SIIN-
FEKL complexes was assessed by staining with the 25-
D1.16 monoclonal antibody [36]. As shown in Figure 1B,
EL4 stably transfected clones, denoted EL4/HEL-ER-SIIN-
FEKL and EL4/HEL-Cyto-SIINFEKL, can process and
present SIINFEKL derived from an ER-localized or a
cytosolic chimeric protein, respectively. These two clones,
which display similar amounts of Kb-SIINFEKL at the cell
surface, were used in further experiments.
UPR activation impairs MHC I surface expression
Various pharmacological agents are widely used to induce
ER stress. For instance, tunicamycin and dithiothreitol are
known to cause ER stress by preventing N-linked glyco-
sylation or disrupting disulfide bond formation in the ER,
respectively [37,38]. However, since MHC I proteins are
glycosylated and contain disulfide bonds, we surmised
that tunicamycin and dithiothreitol would directly hinder
the assembly of MHC I molecules. We elected to use more
physiological ER stress stimuli that should have less dras-BMC Immunology 2009, 10:10 http://www.biomedcentral.com/1471-2172/10/10
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tic effects on the synthesis of MHC I molecules: palmitate
and glucose starvation. Palmitate is a saturated fatty acid
recently shown to cause ER stress by disrupting mainly the
structure and integrity of the ER [39-41]. Palmitate is
abundant in the 'high fat Western diet', which renders this
type of stress more physiological [42]. Glucose starvation
is a common condition present for instance in vascular-
ized bulky tumors and metastases, and is also a prototyp-
ical and strong inducer of ER stress [43].
Activation of the UPR was monitored by quantitative real-
time reverse transcriptase polymerase chain reaction (RT-
qPCR) analysis of BiP, CHOP and the normal and spliced
XBP-1 transcripts, which are known to be induced during
ER stress [19,44]. As expected, treatment of both EL4
transfectants, EL4/HEL-Cyto-SIINFEKL and EL4/HEL-ER-
SIINFEKL (data not shown), with palmitate for 18 hours
induced a mild UPR that was similar in both EL4 cell lines
and of lesser magnitude than that induced by tunicamycin
stimulation (Figure 2A). Similarly, we monitored UPR
induction in EL4 cell lines grown in high glucose (4.5 mg/
ml), low glucose (1 mg/ml) or no glucose-containing
medium for different time durations (Figure 2B). BiP,
XBP-1 and CHOP transcripts were significantly induced in
both EL4 cell lines when they were completely deprived of
glucose for 18 or 24 hours, indicating activation of the
UPR under these conditions. However, none of these UPR
markers were upregulated in cells grown in low glucose-
containing medium, suggesting that 1 mg/ml of glucose is
sufficient to keep the homeostasis of the ER in EL4 cells.
The notable point here is that glucose starvation for 18–
24 h induced a robust UPR that seemed to be of greater
magnitude than that induced by palmitate (Figures 2A
and 2B). Thus, ER stress induced by palmitate treatment
or glucose starvation activates the UPR in EL4 cells, albeit
to different extents.
To evaluate the effect of the UPR on MHC I expression, we
quantified by flow cytometry surface levels of H2Kb and
H2Db in both EL4 cell lines submitted to ER stress (Figure
3). Cells in later apoptotic stages were excluded from the
analysis by gating on propidium iodide-negative cells.
EL4 stable transfectants express the SIINFEKL peptide derived from HEL targeted to the ER or to the cytosol Figure 1
EL4 stable transfectants express the SIINFEKL peptide derived from HEL targeted to the ER or to the cytosol. 
(A) Schematic representation of the constructs used to generate EL4 stable transfectants. Modified coding sequences of HEL 
[34,35] in frame with the region coding for the ovalbumin-derived peptide SIINFEKL and its flanking region were cloned into 
the pIRES-EGFP2 vector. HEL-ER-SIINFEKL possesses HEL N-terminal signal sequence (ss) and the ER-retention signal KDEL 
and targets HEL to the ER; HEL-Cyto-SIINFEKL lacks the N-terminal signal sequence and the ER-retention signal and targets 
HEL to the cytoplasm (see materials and methods). (B) EL4 stable transfectants express Kb-SIINFEKL at the cell surface. EL4 
cells were transfected with the pIRES-EGFP2 vector encoding HEL-ER-SIINFEKL or HEL-Cyto-SIINFEKL. Stable transfectants 
were selected by repeated cycles of FACS of EGFP-positive cells combined with drug resistance (1000 μg/ml of G418). Cells 
were stained with 25-D1.16 monoclonal antibody, recognizing the Kb-SIINFEKL complex, followed by staining with APC-conju-
gated anti-mouse IgG1 as secondary antibody. Depicted in the graphs are EGFP and Kb-SIINFEKL MFI values of untransfected 
EL4 cells (upper left), EGFP-transfected cells (lower left) and the two representative clones that were used in further studies: 
EL4/HEL-ER-SIINFEKL (upper right) and EL4/HEL-Cyto-SIINFEKL (lower right). Percentages represent the proportion of cells 
expressing EGFP and Kb-SIINFEKL.
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Activation of the UPR with palmitate reduced cell surface
expression of H2Db and H2Kb by 30–40% in both cell
lines (Figure 3A). Likewise, we evaluated whether UPR
induced by glucose deprivation also affected MHC I sur-
face expression. EL4 stable cell lines were incubated in
medium lacking glucose or containing low glucose (1 mg/
ml) or high glucose (4.5 mg/ml) for 18 hours and MHC I
surface levels were measured by flow cytometry (Figure
3B). MHC I expression was impaired in cells grown both
in low or no glucose conditions, albeit to a different
extent. Cells that were completely deprived of glucose
expressed only 25–30% of normal H2Kb and H2Db levels,
similar to the decline produced by tunicamycin (not
shown). On the contrary, cells incubated in low glucose
medium were less affected since around 70–90% of nor-
mal H2Kb and H2Db levels were detected. Of note, a glu-
cose dose of only 1 mg/ml was sufficient to raise MHC I
levels by around three-fold (compare no-glucose with low
glucose conditions in Figure 3B). As observed in the case
of palmitate treatment, glucose starvation caused a similar
downregulation of MHC I in the two stable cell lines (Fig-
ure 3B). These results show that ER stress induced by glu-
cose deprivation or palmitate treatment causes decreased
expression of surface MHC I molecules in EL4 cells.
Posttranscriptional mechanism(s) cause decreased 
expression of surface MHC I molecules during ER stress
Since the UPR blocks transcription of numerous genes
and can provoke premature degradation of mRNAs
encoding secreted or membrane proteins [22], we investi-
gated whether decreased MHC I surface expression was
due to downregulation of MHC I transcripts. Using RT-
qPCR, we found that mRNA expression levels of H2Kb,
H2Db and β2m were unaffected in glucose-deprived or
palmitate-treated cells (Figure 4A). In fact, the abundance
of the β2m transcript, whose protein is essential for the
formation of stable MHC I-peptide complexes, tended to
increase in stressed cells relative to control cells (although
this increase was not statistically significant). We therefore
conclude that UPR induced with palmitate or glucose star-
vation leads to posttranscriptional attenuation of cell sur-
face MHC I molecules.
To test whether diminished MHC I upon ER stress
occurred only at the cell surface, we quantified total MHC
I protein amount from whole lysates of cells previously
treated with palmitate or deprived of glucose. We found
that none of these conditions affected the steady state
level of MHC I (Figure 4B). Nevertheless, one of the con-
sequences of UPR activation is attenuation of protein syn-
thesis [18]. Thus, we tested whether the UPR could impact
on synthesis of MHC I in metabolically-labeled EL4 cells
previously subjected to glucose deprivation or palmitate
treatment for 18 hours. We found that glucose starvation,
and to a much lesser extent palmitate, curtailed the syn-
Induction of ER stress in EL4 cells Figure 2
Induction of ER stress in EL4 cells. (A) UPR activation 
induced by palmitate treatment. EL4/HEL-Cyto-SIINFEKL 
cells were either non-treated or treated with 0.25 mM of 
palmitate or 2.5 μg/ml of tunicamycin for 18 hours. BiP, XBP-
1 and CHOP mRNA levels were analyzed by RT-qPCR. 
Expression levels were normalized to the endogenous con-
trol gene β-actin. Transcript levels of treated cells were com-
pared with basal mRNA values of untreated cells (dotted line), 
which were set to 1. (B) UPR activation induced by glucose 
deprivation. EL4 stable cell lines were incubated in DMEM 
medium lacking glucose or containing low glucose (1 mg/ml) 
or high glucose (4.5 mg/ml) for different durations. BiP, XBP-
1 and CHOP mRNA levels were analyzed by RT-qPCR. 
Expression levels were normalized to the endogenous con-
trol gene β-actin. Transcript levels of cells incubated under 
low (purple) or no glucose (green) were compared to levels of 
cells grown in high glucose medium (dotted line), which were 
set to 1. Similar results were obtained with EL4/HEL-ER-
SIINFEKL cells (data not shown). Bars represent the mean 
and SD from three independent experiments performed in 
triplicate. *P < 0.05 when comparing untreated with palmi-
tate- or tunicamycin-treated cells, or high glucose with low 
glucose or no glucose conditions.
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ER stress impairs MHC I surface expression Figure 3
ER stress impairs MHC I surface expression. (A) Decreased MHC I surface expression induced by palmitate treatment. 
EL4 cells were either non-treated (dotted line) or treated with 0.25 mM of palmitate (orange) for 18 hours. EL4/HEL-Cyto-SIIN-
FEKL (top) and EL4/HEL-ER-SIINFEKL (bottom) cells were stained with antibodies against H2Kb, H2Db or the corresponding 
isotypic control and analyzed by flow cytometry. Representative histograms of one of three independent experiments are 
depicted. Bars represent % of MFI intensity in treated EL4/HEL-Cyto-SIINFEKL (blue) and EL4/HEL-ER-SIINFEKL (red) cells rel-
ative to untreated cells (dotted line). Differences between untreated and treated cells are all significant (P < 0.05). (B) Decreased 
MHC I surface expression induced by glucose deprivation. EL4 cells were incubated in medium lacking glucose (green) or con-
taining low glucose (1 mg/ml) (purple) or high glucose (4.5 mg/ml) (dotted line) for 18 hours and analyzed as in A. Bars represent 
% of MFI intensity in glucose-deprived EL4/HEL-Cyto-SIINFEKL (blue) and EL4/HEL-ER-SIINFEKL (red) cells relative to 
untreated cells (dotted line). Bars represent the mean and SD from three independent experiments performed in triplicate. Dif-
ferences between control and glucose-deprived cells are all significant (P < 0.05).
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thesis of new MHC I molecules by around 40% and 5%,
respectively (Figure 4C). Of note, the MHC I band in the
no-glucose condition migrated faster than the bands in
the control and the palmitate conditions. This effect is
likely due to incomplete glycosylation of MHC I mole-
cules in glucose-deprived cells. Thus, under our experi-
mental conditions, ER stress did not affect the level of
MHC I transcripts nor the total amount of MHC I protein
(Figure 4A and 4B), but decreased the synthesis of new
MHC I molecules (Figure 4C) and the amount of MHC I
molecules at the cell surface (Figure 3).
Decreased overall protein synthesis hinders MHC I-
peptide presentation during ER stress
To understand how ER stress decreased cell surface expres-
sion of MHC I proteins, we evaluated the impact of ER
stress on surface expression of a variety of glycoproteins
(Figure 5). As shown before, palmitate treatment and glu-
cose starvation severely impacted MHC I surface level. In
contrast, surface expression of glycoproteins CD32,
CD45.2, TCR-β and CD5 (Ly1) was minimally or not
affected. These results show that the deleterious impact of
the UPR is more severe on surface MHC I expression than
on other glycoproteins. This suggests that reduction in the
amount of cell surface MHC I molecules during ER stress
cannot be attributed solely to defective MHC I synthesis.
That contention is further supported by two elements.
First, a 5% decline of MHC I synthesis in palmitate-treated
cells (Figure 4C) is not commensurate with a 30–40%
reduction of MHC I molecules at the cell surface (Figure
3A). Second, the total amount of MHC I proteins was not
affected in stressed cells (Figure 4B), suggesting that MHC
I proteins were relatively stable and that they did not reach
the cell surface because they were not properly loaded
with their peptide cargo and were therefore retained in the
ER.
Assembly and presentation of MHC I-peptide complexes
at the cell surface requires peptide delivery to the ER
[28,45]. Since MHC I binding peptides derive mostly from
recently synthesized proteins [23], we investigated
whether glucose starvation and palmitate treatment atten-
uated protein translation. To test this idea we determined
the rate of global protein synthesis in ER-stressed EL4 cells
by measuring the rate of [3H]leucine incorporation. Trans-
lation was severely compromised in cells deprived of glu-
cose, which showed a 75% decline in the rate of protein
synthesis (Figure 6A). The impact on protein synthesis
was comparable to that observed with the translation
inhibitor cycloheximide (Figure 6A). Protein synthesis
was less attenuated in palmitate-treated cells, but yet
decreased by approximately 25%. Of note, ER stress pro-
duced similar inhibition of protein synthesis in EL4/HEL-
Cyto-SIINFEKL and EL4/HEL-ER-SIINFEKL cells.
Following UPR signaling, inhibition of cap-dependent
translation occurs via phosphorylation of Ser51 of the
translation initiation factor eIF2α by activated PERK [18].
In line with this, we detected a rapid phosphorylation of
eIF2α in EL4 cells after only 1 hour of glucose deprivation
or treatment with palmitate (Figure 6B). This phosphor-
ylated form persisted for 24 hours in both cases. These
results show that eIF2α-mediated inhibition of protein
synthesis occurs during glucose starvation or palmitate
treatment and support the idea that impaired surface
MHC I expression is caused by an inadequate peptide sup-
ply.
Differential cell surface presentation of ER- vs. cytosol-
derived peptide by MHC I molecules during ER stress
In the next series of experiments, we studied the impact of
ER stress on MHC I-peptide presentation, using the SIIN-
FEKL peptide as a model. Kb-SIINFEKL surface expression
was quantified by flow cytometry in EL4 stable cell lines
submitted to ER stress by glucose deprivation or palmitate
treatment for 18 hours. We found that abundance of cell
surface Kb-SIINFEKL decreased by more than 40% in cells
that were completely deprived of glucose relative to con-
trol cells (Figure 7A). Similarly, Kb-SIINFEKL complexes
were diminished by 20% or more in the presence of
palmitate and by 10% in cells grown in the presence of
low glucose. Thus, consistent with what we observed in
the case of surface MHC I molecules, MHC I-peptide pres-
entation is reduced during ER stress.
In addition, we found that although Kb-SIINFEKL expres-
sion was reduced in both cell lines upon ER stress, EL4/
HEL-ER-SIINFEKL cells presented significantly more com-
plexes than EL4/HEL-Cyto-SIINFEKL cells (Figure 7A).
This difference occurred during complete glucose starva-
tion, or treatment with palmitate (Figure 7A) or tunicamy-
cin (not shown), but not when the glucose concentration
was low, suggesting that it is UPR-specific (Figure 7A). Of
note, both cell lines displayed similar amounts of Kb-
SIINFEKL complexes under normal conditions (Figure 1B
and Figure 7B top). We wish to emphasize that differences
in abundance of Kb-SIINFEKL among the two types of EL4
transfectants during ER stress (Figure 7A) cannot be
ascribed to an overall difference in expression of H2Kb at
the cell surface (Figure 3A and 3B). We therefore conclude
that during ER stress, diminution of Kb-SIINFEKL presen-
tation was more drastic when the peptide derived from a
protein localized in the cytosol than from an ER-retained
protein.
Cell surface Kb-SIINFEKL complexes have been shown to
be very stable [46]. We therefore postulated that monitor-
ing Kb-SIINFEKL in the aforementioned experimental
conditions might lead us to underestimate the impact of
ER stress on exportation of "new" MHC I-peptide com-BMC Immunology 2009, 10:10 http://www.biomedcentral.com/1471-2172/10/10
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plexes at the cell surface. Thus, in the next series of exper-
iments, we took advantage of the fact that cell surface
MHC I-peptide complexes can be disrupted by mild acid
elution at pH 3.3 [47-49]. EL4 stable cell lines were sub-
mitted or not to ER stress, then existent Kb-SIINFEKL com-
plexes were acid stripped and generation of new
complexes was measured at different time points. We rea-
soned that in this way we could directly assess the effect of
the UPR on the generation of new Kb-SIINFEKL com-
plexes. In control conditions, cells rapidly re-expressed Kb-
SIINFEKL and initial control levels were reached 9 hours
after acid stripping (Figure 7B, top). Notably, EL4/HEL-
ER-SIINFEKL and EL4/HEL-Cyto-SIINFEKL cell lines
showed similar kinetics. In contrast, stressed cells were
not able to reach basal amount of Kb-SIINFEKL after acid
strip (Figure 7B, middle and bottom). This effect was
more striking in glucose-starved than in palmitate-treated
cells, consistent to what we observed for MHC I expres-
sion (Figure 5B). Remarkably, EL4/HEL-ER-SIINFEKL
cells generated significantly more cell surface Kb-SIINFEKL
complexes than EL4/HEL-Cyto-SIINFEKL during ER stress
(Figure 7B, middle and bottom). It should be noted that
it was not possible to measure generation of complexes at
time points later than 9 hours after acid strip, since at this
time cells had already been stressed for 24 hours and cell
death became a confounding variable. We conclude that
ER stress decreases presentation of both existent (Figure
7A) and newly generated (Figure 7B) Kb-SIINFEKL com-
plexes and that it differentially affected abundance of
SIINFEKL derived from an ER- vs. a cytosol-localized pro-
tein.
Changes in stability of cytosolic and ER-retained HEL 
during ER stress
As mentioned above, newly synthesized proteins are the
major substrates for MHC I processing. In addition, it has
been shown that the protein synthesis machinery of the
cytosol and ER compartments is under distinct regulatory
control during the UPR [50]. Thus the differential effect of
ER stress on presentation of ER- or cytosol-derived SIIN-
FEKL could be due to changes in the translation rates of
the source proteins. We explored this possibility and com-
pared the synthesis rate of HEL-ER and HEL-Cyto in EL4
stable cell lines under normal conditions and during glu-
cose starvation in metabolic labeling experiments. The
rate of synthesis of cytosolic HEL and ER-retained HEL
was not affected by glucose deprivation (Figure 8A).
Hence, the different abundance of SIINFEKL at the surface
of these cell lines during ER stress is not due to changes in
the rate of synthesis of the precursor proteins.
MHC I-peptide presentation not only relies on protein
synthesis but also on protein degradation. Therefore, we
explored whether the stability of these proteins could be
differentially affected during ER stress. EL4 stable cell lines
ER stress impairs cell surface MHC I expression through  posttranscriptional mechanism(s) Figure 4
ER stress impairs cell surface MHC I expression 
through posttranscriptional mechanism(s). EL4 cells 
were incubated in DMEM control medium containing glucose 
(4.5 mg/ml), or in medium lacking glucose or supplemented 
with 0.25 mM of palmitate for 18 hours. (A) ER stress does 
not decrease MHC I mRNA levels. H2Kb, H2Db and β2m 
mRNA levels were assessed and analyzed by RT-qPCR. 
Expression levels were normalized to the endogenous con-
trol gene β-actin. Transcript levels of glucose-starved (green) 
or palmitate-treated (orange) cells were compared with basal 
mRNA values of control cells (dotted line), which were set to 
1. Bars represent the mean and SD from three independent 
experiments performed in triplicate. No significant differ-
ences were detected between untreated and treated cells (P 
< 0.05). (B) ER stress does not affect total MHC I protein 
amount. MHC I proteins from whole cell lysates were 
detected by Western blot with anti-MHC I antibodies. α-
tubulin was used as loading control. A representative image 
of three independent experiments is shown. (C) ER stress 
differentially affects synthesis of MHC I. EL4 cells were incu-
bated in control conditions, deprived of glucose or treated 
with 0.25 mM of palmitate for 17 hours and pulse-labeled 
with [35S]methionine/[35S]cysteine for 1 hour. Cell extracts 
were lysed and subjected to immunoprecipitation with anti-
MHC I antibody or the corresponding isotypic antibody. 
Immunoprecipitated proteins were separated by SDS-PAGE 
and analyzed by fluorography. One representative experi-
ment out of two is shown.
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were deprived or not of glucose for 18 hours and then
treated with cycloheximide to inhibit protein synthesis.
The protein levels of cytosolic HEL and ER-retained HEL
were assessed by Western blot thereafter. We observed an
increased stability of cytosolic HEL in the absence of glu-
cose compared to control conditions (Figure 8B and 8C).
In contrast, the stability of ER-retained HEL was the same
in control conditions and during glucose starvation. These
results suggest that reduced presentation of SIINFEKL by
H2Kb when the peptide derives from the cytosolic protein
compared to the ER-retained protein is due to increased
stability of the cytosolic protein during ER stress.
Discussion
The ER stands at the crossroad of two fundamental cellu-
lar processes: MHC I antigen presentation and UPR activa-
tion during ER stress. The UPR regulates protein synthesis
and degradation, chaperoning and decay of ER mRNAs
[14,15]. Thus, it has enormous potential to impinge on
MHC I antigen processing which relies on all these proc-
esses. Here, we assessed the effect of ER stress on the final
outcome of antigen processing and presentation: MHC I-
peptide abundance. We demonstrated that ER stress
induced by tunicamycin, palmitate or glucose depriva-
tion, decreases peptide presentation by MHC I molecules.
This finding is consistent with prior studies reporting
reduced MHC I surface levels in human cells expressing a
mutant HFE protein or overexpressing transcriptionally
active isoforms of UPR-activated transcription factors
ATF-6 and XBP-1 [51,52]. Recently, reduced expression of
MHC I molecules was also observed in antigen presenting
cells during palmitate treatment [53]. Thus, diminution of
MHC I surface expression upon UPR activation appears to
be a generalized phenomenon occurring during ER stress
induced by a variety of stimuli (pharmacological agents,
mutant proteins, glucose starvation and saturated fatty
acid).
Since the UPR provokes the degradation of ER-localized
mRNAs [22], accelerated decay of MHC I mRNA might
have been responsible for the reduction of cell surface
MHC I expression. However, the presence of normal lev-
els of MHC I and β2m transcripts allowed us to exclude
this possibility. During ER stress, transducers of the UPR
seek to decrease the ER burden by suppressing translation
initiation through phosphorylation of eIF2α by activated
PERK [14,15]. We demonstrated that inhibition of protein
synthesis and phosphorylation of eIF2α did occur in EL4
cells treated with palmitate or deprived of glucose. Of
note, the effect of these two treatments on phosphoryla-
tion of eIF2α was similar, yet inhibition of overall protein
synthesis was more severe in glucose-deprived than in
palmitate-treated cells. We presume that this discrepancy
was due to brisk inhibition of the mammalian target of
rapamycin (mTOR) pathway during glucose starvation
[54]. Inhibition of mTOR blocks phosphorylation of p70
ribosomal S6 kinase and eukaryotic initiation factor 4E
binding protein 1 and thereby leads to inhibition of pro-
tein synthesis. Given the dramatic inhibition of protein
synthesis during glucose starvation, it was notable that the
translation rate of the two HEL variants was not affected.
Differential effects of ER stress on surface expression of vari- ous glycosylated proteins Figure 5
Differential effects of ER stress on surface expression 
of various glycosylated proteins. EL4 cells were incu-
bated in high glucose (4.5 mg/ml) medium (dotted line) or in 
medium lacking glucose (green) or supplemented with 2.5 
mM of palmitate (orange) for 18 hours. (A) Effect of glucose 
starvation or palmitate treatment on surface expression of 
glycosylated proteins. Surface expression of H2Kb, H2Db, 
CD32, CD45.2, TCR-β and CD5 (Ly1) was determined by 
flow cytometry analysis. Representative histograms of one of 
three independent experiments are depicted. (B) Compara-
tive effect of palmitate treatment and glucose starvation on 
surface expression of glycosylated proteins. Bars represent % 
of MFI intensity in glucose-starved (green) or palmitate-
treated (orange) cells relative to control cells (dotted line). 
Bars represent the mean and SD from three independent 
experiments. *P < 0.05 and **P < 0.01 when comparing no 
glucose or palmitate with control conditions.
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That feature of our HEL variants is not unique as there are
several proteins whose synthesis is unaffected during ER
stress [9,54].
We found that ER stress-induced inhibition of overall pro-
tein synthesis curtails the synthesis of new MHC I mole-
cules. Nevertheless, we do not believe that decreased
synthesis of MHC I proteins per se was a leading factor
responsible for decreased levels of MHC I molecules at the
cell surface. Our assertion is based on three lines of evi-
dence: i) a 5% decline of MHC I synthesis in palmitate-
treated cells was not commensurate with a drop of 30–
40% of surface MHC I, ii) during ER stress, cell surface lev-
els of MHC I proteins were decreased much more than
those of other glycoproteins that must also pass through
the same maturation process and quality control in order
to be exported at the cell surface, and iii) the total amount
of intracellular MHC I proteins was not decreased during
stress suggesting that MHC I molecules did not reach the
cell surface mainly because they were sequestered in the
ER. In addition, de Almeida et al. showed that a partial
UPR signaling induced by overexpression of ATF-6 or
XBP-1 in the absence of genuine stress stimulus also
resulted in decreased MHC I surface expression [52].
MHC I heavy chains and β2m are present in excess in the
ER. The limiting factor in the assembly and presentation
of MHC I-peptide complexes is peptide delivery to the ER
[28,45]. Moreover, peptides presented by MHC I mole-
cules derive mainly from proteins that are degraded a few
seconds or minutes after their synthesis as opposed to sta-
ble proteins with a slow turnover. Thus, generation of
MHC I peptide ligands is tightly coupled to ongoing pro-
tein synthesis and inhibition of translation rapidly
decreases the amount of cell surface MHC I-peptide com-
plexes [55]. Our favorite hypothesis is therefore that
decreased MHC I presentation during ER stress is due
mainly, albeit not exclusively, to restriction of peptide
availability. Given that MHC I molecules preferentially
sample polypeptides that are being actively translated
[55], we posit that global attenuation of protein synthesis
caused by palmitate and glucose starvation limits the
amount of a vast repertoire of peptides available for inser-
tion in MHC I molecules. Nevertheless, we do not exclude
the possibility that defective synthesis of MHC I and other
possible mechanisms such as inappropriate loading of
peptides, contribute to diminution of MHC I-peptide
presentation. This would be mainly the case of peptides
deriving from proteins whose synthesis is not curtailed
upon ER stress. For instance, our results show that ER
stress diminished presentation of Kb-SIINFEKL complexes
even though the synthesis of the proteins source of this
particular peptide (HEL variants) was not affected.
A main conclusion of our work is that ER stress-induced
attenuation of MHC I-peptide presentation is more severe
when the source protein is localized in the cytosol than in
the ER. The difference between proteins in these two cell
compartments was UPR-specific because it did not occur
in the low glucose condition in which no UPR markers
were significantly induced. Our cell lines expressing HEL-
Cyto-SIINFEKL and HEL-ER-SIINFEKL displayed identical
responses to palmitate treatment or glucose starvation.
The two cell lines showed similar upregulation of UPR
markers and equivalent reduction in cell surface levels of
H2Kb and H2Db during ER stress. Despite the fact that the
translation rates and degradation profiles normally differ
in both cell lines, they displayed similar levels of Kb-SIIN-
FEKL complexes under steady-state conditions. On the
contrary, presentation of Kb-SIINFEKL complexes was dif-
ferentially affected in these cell lines during ER stress.
Only 1–2 out of every 10,000 peptides generated by the
proteasome bind to MHC I molecules [28]. Our data
therefore beg the question: how would an ER-retained
protein generate more peptides than a cytosolic protein
ER stress inhibits protein synthesis through phosphorylation  of eIF2α in EL4 stable cell lines Figure 6
ER stress inhibits protein synthesis through phospho-
rylation of eIF2α in EL4 stable cell lines. (A) Decreased 
overall rate of protein synthesis upon ER stress. EL4 stable 
cell lines were deprived of glucose, treated with 0.25 mM of 
palmitate, 100 μg/ml of cycloheximide or cultured under 
control conditions for 19 hours. [3H]Leucine (10 μCi/mL) 
was added during the last hour. The rate of protein synthesis 
was measured by [3H]leucine incorporation. The results are 
expressed as the % of [3H]leucine incorporation per cell rela-
tive to control cells (dotted line) in EL4/HEL-Cyto-SIINFEKL 
(blue) and EL4/HEL-ER-SIINFEKL (red) cells. Bars depict the 
mean and SD of one representative experiment performed in 
triplicate. Differences between untreated and treated cells 
are all significant (P < 0.05). (B) Phosphorylation of eIF2α. 
EL4 cells were deprived of glucose or treated with 0.25 mM 
of palmitate for different durations over a 24-h period. Total 
cell lysates were immunoblotted against phosphorylated 
eIF2α (Ser51) or total eIF2α. α-tubulin was used as loading 
control. One representative experiment out of three is 
shown.
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during ER stress? We showed that this difference was not
due to variations in the translation rate of each precursor
protein during ER stress. This suggests that differences in
peptide presentation resulted from discrepancies in the
degradation of ER vs. cytosolic proteins during ER stress.
UPR transducers specifically enhance degradation of pro-
teins in the secretory pathway in order to decrease the ER
folding load. During ER stress, cotranslational protein
translocation is inhibited and newly-synthesized ER pro-
teins are triaged for degradation (ERAD) [38,56,57]. Fur-
thermore, retrotranslocation of ER-resident proteins in
the cytosol for proteasomal degradation is enhanced [58].
Based on this, we expected to see an increased degradation
of the ER-retained HEL variant during ER stress. However,
the stability of the ER-retained protein remained
unchanged while the stability of the cytosolic HEL variant
increased during ER stress. The most parsimonious expla-
nation for the latter findings would be that during ER
stress, proteasomes focus primarily on degradation of ER
as opposed to cytosolic proteins. This would be consistent
with the fact that the primary role of the UPR is to
decrease the folding burden in the stressed ER. We there-
fore propose that regulation of proteasomal degradation
during ER stress leads to a reduction in MHC I peptide lig-
ands generated from cytosolic precursors. Further studies
will be needed to determine whether this concept can be
generalized to other proteins and other MHC I-associated
peptides.
What might be the impact of the UPR on immune recog-
nition of infected and neoplastic cells? Paradoxically, if
the decreased generation of MHC I-peptide complexes
results mainly from inhibition of translation, it could
facilitate recognition of virus-infected cells. Phosphoryla-
tion of eIF2α hampers canonical cap-dependent transla-
tion initiation which regulates synthesis of 95–98% of
cellular mRNAs [9]. However, some viruses can use inter-
nal ribosomal entry sites in their 5' noncoding region to
initiate cap-independent translation [9,59]. Thus, by pref-
erentially repressing presentation of self peptides, the UPR
could facilitate recognition of viral peptides (the needle in
the haystack [60]). The potential impact of the UPR on
recognition of neoplastic cells is not inherently obvious.
On the one hand, by repressing production of MHC I-pep-
tide complexes, the UPR may hinder presentation of
tumor antigens to CD8 T cells. Indeed, generation of opti-
mal CD8 T cell responses is promoted by high epitope
density on antigen presenting cells [61,62]. However, an
elegant study by Schwab et al. has shown that upon induc-
tion of eIF2α phosphorylation by ER stress, cells can gen-
erate MHC I-associated peptides derived from cryptic
translational reading frames [63]. Expression of such cryp-
tic peptides by neoplastic cells might trigger recognition of
stressed cells by CD8 T lymphocytes. Finally, a high fat
diet rich in saturated fatty acids such as palmitate, could
Increased presentation of SIINFEKL peptide derived from  ER-localized relative to cytosolic HEL protein during ER  stress Figure 7
Increased presentation of SIINFEKL peptide derived 
from ER-localized relative to cytosolic HEL protein 
during ER stress. (A) ER stress differentially affects surface 
expression of Kb-SIINFEKL complexes. EL4 stable cell lines 
were incubated in medium lacking glucose or containing low 
glucose (1 mg/ml) or high glucose (4.5 mg/ml) or supple-
mented with palmitate (2.5 mM) for 18 hours. Kb-SIINFEKL 
abundance was assessed with the 25-D1.16 monoclonal anti-
body and APC-conjugated anti-mouse IgG1 antibody. Graph 
represents MFI values of glucose-deprived EL4/HEL-Cyto-
SIINFEKL (blue) or EL4/HEL-ER-SIINFEKL (red) cells normal-
ized to values of control cells, which were set to 1 (dotted 
line). (B) ER stress differentially affects surface expression of 
newly generated Kb-SIINFEKL complexes. EL4 stable cell 
lines were incubated under control conditions (top), deprived 
of glucose (middle) or treated with 0.25 mM of palmitate (bot-
tom) for 18 hours. Existent MHC-I complexes were eluted by 
acid strip and expression of new Kb-SIINFEKL complexes 
was assessed as in A at the indicated times. MFI values of 
unstripped cells incubated under normal conditions and rep-
resenting normal level of Kb-SIINFEKL in each cell line were 
used to normalize MFI values of stripped cells. Bars represent 
the mean and SD from three independent experiments per-
formed in triplicate. *P< 0.05 and **P < 0.01 when comparing 
normalized Kb-SIINFEKL expression in EL4/HEL-Cyto-SIIN-
FEKL with that of EL4/HEL-ER-SIINFEKL.
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potentiate the conditions of ER stress found in tumour
cells and lessen even more MHC I-peptide presentation.
In fact, obesity has been associated with increased suscep-
tibility to infection and impaired immune responses
[53,64]. We anticipate that high-throughput sequencing
of MHC I-associated peptides [33] will be necessary to
comprehensively evaluate how ER stress molds the pep-
tide repertoire (in terms of both abundance and diver-
sity), and to gain further insights into the global impact of
the UPR on recognition of stressed cells by CD8 T lym-
phocytes.
Conclusion
Our work shows that ER stress impinges on the MHC I
peptide repertoire in two ways: by decreasing overall
MHC I-peptide presentation and by changing the relative
contribution of ER- vs. cytosol-proteins to the MHC I pep-
tide repertoire. Since ER stress is a characteristic feature of
infection and malignancy, dysregulation of MHC I-pep-
tide presentation could have major implications in the
recognition of infected and transformed cells by CD8 T
lymphocytes.
Methods
Cell lines
EL4 cells were maintained in Dulbecco's modified Eagle's
medium (DMEM) (GIBCO Burlington, ON, Canada) sup-
plemented with 5% fetal bovine serum (FBS) and antibi-
otics. EL4 stable transfectants were grown in the same
medium supplemented with 1000 μg/ml of G418.
DNA constructs
pHYK/HEL-ER/myc and pCMV/HEL-Cyto/myc plasmids
encoding ER-retained or cytoplasmic HEL, respectively,
were provided by S. Ostrand-Rosenberg (University of
Maryland, Baltimore, USA). The pHYR/HEL-ER plasmid
contains the HEL gene (that includes a signal sequence)
fused to the ER-retention signal KDEL, whereas pCMV/
HEL-Cyto codes for HEL with a modified N-terminus and
lacks ER-retention signal. These plasmids have success-
fully been shown to target HEL to the ER or to the cytosol
[34,35]. pHYK/HEL-ER and pCMV/HEL-Cyto were
sequenced to ascertain correct sequence and reading
frame. Fragments coding for HEL-ER or HEL-Cyto were
fused by PCR to the region coding for the ovalbumin-
derived peptide SIINFEKL, flanked by a sequence of 18 bp
(LEQLE-SIINFEKL-TEWTS, here referred to as SIINFEKL)
to ensure proteasome- and TAP-dependent peptide
processing [65,66]. PCR amplification products were sub-
cloned into the pPCR-Script Amp cloning vector (Strata-
gene, Cedar Creek, TX, USA). HEL-ER-SIINFEKL or HEL-
Cyto-SIINFEKL were excised and cloned into the bicis-
tronic pIRES-EGFP2 vector (Clontech, Mountain View,
CA, USA) to generate pIRES-EGFP2/HEL-ER-SIINFEKL
and pIRES-EGFP2/HEL-Cyto-SIINFEKL (Figure 1A). Both
Stability of cytosolic HEL and ER-retained HEL during ER  stress Figure 8
Stability of cytosolic HEL and ER-retained HEL dur-
ing ER stress. (A) Rate of synthesis of cytosolic HEL and 
ER-retained HEL. EL4/HEL-ER-SIINFEKL and EL4/HEL-Cyto-
SIINFEKL cells were incubated in control conditions (4.5 mg/
ml) or deprived of glucose for 17 hours and pulse-labeled 
with [35S]methionine/[35S]cysteine for 1 hour. Cell extracts 
were lysed and subjected to immunoprecipitation with anti-
HEL antibody. Immunoprecipitated proteins were separated 
by SDS-PAGE and analyzed by fluorography. One represent-
ative experiment out of two is shown. (B) Stability of 
cytosolic HEL and ER-retained HEL. EL4/HEL-ER-SIINFEKL 
and EL4/HEL-Cyto-SIINFEKL cell lines were incubated in 
control conditions (4.5 mg/ml) or deprived of glucose for 18 
hours. Then, 100 μg/ml of cycloheximide were added to 
inhibit protein synthesis and cell lysates taken at different 
times were immunoblotted against HEL or β-actin (used as 
loading control). One representative immunoblot out of 
three is shown. (C) Graph represents relative intensities of 
HEL (means and SD) from three independent experiments. 
*P < 0.05 when comparing control vs. no glucose conditions.
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constructs were sequenced to ascertain correct sequence
and reading frame.
Stable transfectants
EL4/HEL-ER-SIINFEKL and EL4/HEL-Cyto-SIINFEKL
were generated by transfecting EL4 cells with the appropri-
ate HEL-containing pIRES-EGFP2 plasmid. Transfections
were done with Lipofectamine LTX Reagent (Invitrogen,
Burlington, ON, Canada) as instructed by the manufac-
turer. 24 hours after transfection, single cells expressing
the brightest signal of EGFP were sorted by fluorescence-
activated cell sorting (FACS) on a FACSAria cell sorter (BD
Biosciences, Mississauga, ON, Canada). Stable transfected
clones were further selected by drug resistance (1000 μg/
ml of G418) in combination with repeated cycles of FACS
of EGFP-positive cells. Clones expressing similar levels of
Kb-SIINFEKL at the cells surface were selected for use in
further experiments.
Stress induction
ER stress was induced by incubating cells in fresh medium
containing 0.25 mM of palmitate or 2.5 μg/ml of tuni-
camycin (Sigma-Aldrich, St. Louis, MO, USA) for the indi-
cated times. Palmitate was prepared as described
previously [67] and delivered as a complex with fatty acid-
free BSA. Glucose starvation was induced by culturing
cells in glucose and sodium pyruvate-free or in low glu-
cose (1000 mg/L) DMEM medium (GIBCO) supple-
mented with 5% dialyzed FBS and antibiotics for the
indicated times. Control cells were grown in high glucose
DMEM medium, containing 4500 mg/L of glucose and
110 mg/L of sodium pyruvate supplemented with 5% FBS
and antibiotics.
Flow cytometry
MHC I molecules at the cell surface were stained with
biotin-conjugated anti-H2Kb (clone AF6-88.5) and biotin-
conjugated anti-H2Db (clone KH95), followed by PeCy5
or APC-conjugated streptavidin. Other cell surface glyco-
sylated proteins were stained with FITC-conjugated anti-
CD45.2, FITC-conjugated anti-CD5 (Ly1), APC-conju-
gated anti-TCR-β and PE-conjugated anti-CD32. All anti-
bodies were purchased from BD Biosciences. Kb-SIINFEKL
levels were determined with the 25-D1.16 antibody [36]
followed by staining with APC-conjugated anti-mouse
IgG1 (Clone X56). Propidium iodide (BD Biosciences)
was used to exclude cells in later apoptotic stages from the
analysis. Cells were analyzed on a BD LSR II flow cytome-
ter using FACSDiva (BS Biosciences) and FCS Express soft-
wares (De Novo Software, Los Angeles, CA, USA) [68,69].
Acid strip assay
MHC I-peptide complexes were eluted with acid treat-
ment as previously described [47-49]. Briefly, cells (~5 ×
105) were resuspended in 0.2 ml of citrate phosphate
buffer at pH 3.3 (0.131 M citric acid/0.066 M Na2HPO4,
NaCl 150 mM) for 1 minute, neutralized with appropriate
medium pH 7.4 and either reincubated in fresh medium
or stained for flow cytometry analysis.
RNA extraction, reverse transcription and RT-qPCR
Total RNA was isolated with TRIzol reagent (Invitrogen)
according to the manufacturer's instructions. Purified
RNA was reverse transcribed using the High Capacity
cDNA reverse transcription Kit with random primers
(Applied Biosystems, Foster City, CA, USA) as described
by the manufacturer. A reference RNA (Stratagene, La
Jolla, CA, USA) was also transcribed in cDNA. Expression
level of target genes was determined using primer and
probe sets from Universal ProbeLibrary https://
www.roche-applied-science.com/sis/rtpcr/upl/index.jsp
or Applied Biosystems (ABI Gene Expression Assays or
SYBR green PCR Master Mix, http://www.appliedbiosys-
tems.com/). Primer sequences are given in Additional file
1. RT-qPCR assay for XBP-1 was designed to amplify both
the normal and spliced forms. Pre-developed TaqMan®
assays for β-actin were used as endogenous controls. RT-
qPCR analyses were performed as described using a
PRISM® 7900 HT Sequence Detection System (Applied
Biosystems) [70]. The relative quantification of target
genes was determined by using the ΔΔCT (cycle thresh-
old) method. Relative expression (RQ) was calculated
using the Sequence Detection System (SDS) 2.2.2 soft-
ware (Applied Biosystems) and the formula RQ = 2-ΔΔCT.
Protein synthesis and metabolic labeling
To measure protein synthesis, EL4 cell lines were cultured
in presence or absence of glucose (4.5 mg/ml) for 18
hours. [3H]Leucine (10 μCi/mL) was added during the
last hour. Cells were washed twice with ice-cold PBS and
fixed for 30 minutes on ice with 10% TCA. Cells were then
rinsed with water and lysed with 0.1 N NaOH. Radioactiv-
ity incorporation was determined with a liquid scintilla-
tion analyzer Tri-CArb 2800TR (Perkin Elmer).
In vivo biosynthetic labeling experiments were carried out
as described previously [71]. Briefly, to evaluate the rate of
synthesis of HEL and MHC I, EL4 cell lines were grown in
control conditions or in the presence of 2.5 mM of palmi-
tate or in the absence of glucose for 17 hours. After this
period, 107 cells per condition were starved of methionine
and cysteine for 30 min. 35S-labeled methionine and
cysteine (220 μCi/mL) were then added for 1 hour. Cells
were harvested and lysed in Triton X-100 buffer (50 mM
Tris pH7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA,
40 mM β-glycerophosphate) supplemented with com-
plete protease inhibitor cocktail (Roche Molecular Bio-
chemicals, Laval, QC, Canada) and phosphatase
inhibitors (1 mM Na3VO4 and 5 mM NaF). Immunopre-
cipitation of ER-retained HEL or cytosolic HEL and MHCBMC Immunology 2009, 10:10 http://www.biomedcentral.com/1471-2172/10/10
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I were performed using anti-HEL antibody purchased
from Affinity BioReagents (Golden, CO, USA) or anti-
H2Kb or anti-H2Db hybridoma culture supernatans anti-
body [49], according to the method described previously
[71]. Proteins were separated by SDS-PAGE and labeled
proteins were detected by fluorography.
Immunoblotting
EL4 cell lines were cultured under control conditions or
submitted to glucose deprivation or palmitate treatment
(0.25 mM) for the indicated times. When indicated, 100
μg/mL of cycloheximide (Sigma-Aldrich) was used for var-
ious durations to measure the stability of HEL variants.
Cells were harvested and lysed in Triton X-100 buffer. The
lysates were cleared by centrifugation and the protein con-
tent was measured by the Bradford method (Biorad, Mis-
sissauga, ON, Canada). Samples were resolved by SDS-
PAGE and immunoblotted with the following antibodies:
anti-β-actin (AC-15) from Sigma-Aldrich, anti-HEL from
Affinity BioReagents, anti-MHC class I (2G5) from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA), anti-α-
tubulin, anti-phospho-eIF2α (Ser51), anti-eIF2α and
horseradish peroxidase (HRP)-conjugated anti-rabbit IgG
from Cell Signaling Technology (Beverly, MA, USA), and
HRP-conjugated goat anti-mouse IgG from BD Pharmigen
(San Diego, CA, USA). Chemiluminescent signal was
detected using a LAS3000 imaging system (Fujifilm,
Tokyo, Japan) and quantification of band intensities was
done using the Multi Gauge v3.0 (Fujifilm) and the
ImageQuaNT v5.0 (Molecular Dynamics, Sunnyvale, CA,
USA) softwares.
Statistical analysis
The means of normally distributed data were compared
using the Student t test, with a P value of < 0.05 consid-
ered significant. Data are presented as the mean and SD.
Whenever the results are expressed as a percentage of con-
trol, the statistical analysis was performed on the actual
value.
Abbreviations
APC: antigen presenting cell; β2m: β2-microglobulin; ER:
endoplasmic reticulum; ERAD: ER-associated degrada-
tion; FACS: fluorescence-activated cell sorting; HEL: hen
egg lysozyme; MHC I: major histocompatibility complex
class I; mTOR: mammalian target of rapamycin; RT-qPCR:
quantitative real-time reverse transcriptase polymerase
chain reaction; UPR: unfolded protein response.
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